Vania Kenanova

1.1k total citations
20 papers, 862 citations indexed

About

Vania Kenanova is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Vania Kenanova has authored 20 papers receiving a total of 862 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Vania Kenanova's work include Monoclonal and Polyclonal Antibodies Research (17 papers), Radiopharmaceutical Chemistry and Applications (10 papers) and Glycosylation and Glycoproteins Research (4 papers). Vania Kenanova is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (17 papers), Radiopharmaceutical Chemistry and Applications (10 papers) and Glycosylation and Glycoproteins Research (4 papers). Vania Kenanova collaborates with scholars based in United States, Norway and Denmark. Vania Kenanova's co-authors include Anna M. Wu, Tove Olafsen, Andrew Raubitschek, Lawrence E. Williams, Paul J. Yazaki, John E. Shively, Desiree Crow, Sanjiv S. Gambhir, Gobalakrishnan Sundaresan and David Colcher and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Analytical Biochemistry.

In The Last Decade

Vania Kenanova

20 papers receiving 846 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vania Kenanova United States 15 675 360 271 96 78 20 862
R Boden United Kingdom 17 529 0.8× 353 1.0× 200 0.7× 58 0.6× 89 1.1× 28 801
Erica Pyles United States 7 587 0.9× 415 1.2× 144 0.5× 94 1.0× 56 0.7× 18 1.1k
Kedan Lin United States 17 750 1.1× 431 1.2× 637 2.4× 224 2.3× 68 0.9× 25 1.1k
Kelly M. Flagella United States 7 489 0.7× 287 0.8× 569 2.1× 84 0.9× 50 0.6× 7 792
Gregory Z. Ferl United States 15 454 0.7× 253 0.7× 209 0.8× 122 1.3× 98 1.3× 30 717
Stephen I. Rudnick United States 9 362 0.5× 391 1.1× 270 1.0× 165 1.7× 45 0.6× 11 798
William van Osdol United States 5 352 0.5× 306 0.8× 176 0.6× 92 1.0× 68 0.9× 7 653
Christophe Lahorte Belgium 12 261 0.4× 316 0.9× 67 0.2× 77 0.8× 71 0.9× 19 583
Thorsten Poethko Germany 16 847 1.3× 247 0.7× 266 1.0× 33 0.3× 99 1.3× 21 1.2k
E Barendswaard United States 10 336 0.5× 123 0.3× 177 0.7× 57 0.6× 150 1.9× 11 626

Countries citing papers authored by Vania Kenanova

Since Specialization
Citations

This map shows the geographic impact of Vania Kenanova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vania Kenanova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vania Kenanova more than expected).

Fields of papers citing papers by Vania Kenanova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vania Kenanova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vania Kenanova. The network helps show where Vania Kenanova may publish in the future.

Co-authorship network of co-authors of Vania Kenanova

This figure shows the co-authorship network connecting the top 25 collaborators of Vania Kenanova. A scholar is included among the top collaborators of Vania Kenanova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vania Kenanova. Vania Kenanova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Williams, Lawrence E., Anna M. Wu, Vania Kenanova, Tove Olafsen, & Paul J. Yazaki. (2014). Numerical Comparison of Iodine-Based and Indium-Based Antibody Biodistributions. Cancer Biotherapy and Radiopharmaceuticals. 29(3). 91–98. 3 indexed citations
2.
Andersen, Jan Terje, Stian Foss, Vania Kenanova, et al.. (2012). Anti-carcinoembryonic Antigen Single-chain Variable Fragment Antibody Variants Bind Mouse and Human Neonatal Fc Receptor with Different Affinities That Reveal Distinct Cross-species Differences in Serum Half-life. Journal of Biological Chemistry. 287(27). 22927–22937. 28 indexed citations
3.
Girgis, Mark D., Vania Kenanova, Tove Olafsen, et al.. (2011). Anti-CA19-9 Diabody as a PET Imaging Probe for Pancreas Cancer. Journal of Surgical Research. 170(2). 169–178. 36 indexed citations
4.
Girgis, Mark D., Vania Kenanova, Tove Olafsen, et al.. (2011). Anti-CA19-9 Diabody As A PET Imaging Probe For Pancreas Cancer. Journal of Surgical Research. 165(2). 258–259. 2 indexed citations
5.
Girgis, Mark D., Tove Olafsen, Vania Kenanova, et al.. (2011). Targeting CEA in Pancreas Cancer Xenografts with a Mutated scFv-Fc Antibody Fragment. EJNMMI Research. 1(1). 24–24. 31 indexed citations
6.
Girgis, Mark D., Tove Olafsen, Vania Kenanova, et al.. (2011). CA19-9 as a Potential Target for Radiolabeled Antibody-Based Positron Emission Tomography of Pancreas Cancer. PubMed. 2011. 1–9. 13 indexed citations
7.
Olafsen, Tove, Shannon J. Sirk, David J. Betting, et al.. (2010). ImmunoPET imaging of B-cell lymphoma using 124I-anti-CD20 scFv dimers (diabodies). Protein Engineering Design and Selection. 23(4). 243–249. 35 indexed citations
8.
Kenanova, Vania, Tove Olafsen, Felix B. Salazar, et al.. (2010). Tuning the serum persistence of human serum albumin domain III:diabody fusion proteins. Protein Engineering Design and Selection. 23(10). 789–798. 28 indexed citations
9.
Barat, Bhaswati, Vania Kenanova, Tove Olafsen, & Anna M. Wu. (2010). Evaluation of Two Internalizing Carcinoembryonic Antigen Reporter Genes for Molecular Imaging. Molecular Imaging and Biology. 13(3). 526–535. 9 indexed citations
10.
Sherman, David J., Vania Kenanova, Eric J. Lepin, et al.. (2010). A differential cell capture assay for evaluating antibody interactions with cell surface targets. Analytical Biochemistry. 401(2). 173–181. 6 indexed citations
11.
Olafsen, Tove, Stephen G. Young, Brandon S.J. Davies, et al.. (2010). Unexpected Expression Pattern for Glycosylphosphatidylinositol-anchored HDL-binding Protein 1 (GPIHBP1) in Mouse Tissues Revealed by Positron Emission Tomography Scanning. Journal of Biological Chemistry. 285(50). 39239–39248. 32 indexed citations
12.
Olafsen, Tove, David J. Betting, Vania Kenanova, et al.. (2009). Recombinant Anti-CD20 Antibody Fragments for Small-Animal PET Imaging of B-Cell Lymphomas. Journal of Nuclear Medicine. 50(9). 1500–1508. 63 indexed citations
13.
Kenanova, Vania, Bhaswati Barat, Tove Olafsen, et al.. (2008). Recombinant carcinoembryonic antigen as a reporter gene for molecular imaging. European Journal of Nuclear Medicine and Molecular Imaging. 36(1). 104–114. 14 indexed citations
14.
Andersen, Jan Terje, Sune Justesen, Burkhard Fleckenstein, et al.. (2008). Ligand binding and antigenic properties of a human neonatal Fc receptor with mutation of two unpaired cysteine residues. FEBS Journal. 275(16). 4097–4110. 29 indexed citations
15.
Kenanova, Vania, Tove Olafsen, Lawrence E. Williams, et al.. (2007). Radioiodinated versus Radiometal-Labeled Anti–Carcinoembryonic Antigen Single-Chain Fv-Fc Antibody Fragments: Optimal Pharmacokinetics for Therapy. Cancer Research. 67(2). 718–726. 70 indexed citations
16.
Ferl, Gregory Z., Vania Kenanova, Anna M. Wu, & Joseph J. DiStefano. (2006). A two-tiered physiologically based model for dually labeled single-chain Fv-Fc antibody fragments. Molecular Cancer Therapeutics. 5(6). 1550–1558. 54 indexed citations
17.
Olafsen, Tove, Vania Kenanova, & Anna M. Wu. (2006). Tunable pharmacokinetics: modifying the in vivo half-life of antibodies by directed mutagenesis of the Fc fragment. Nature Protocols. 1(4). 2048–2060. 45 indexed citations
18.
Kenanova, Vania & Anna M. Wu. (2005). Tailoring antibodies for radionuclide delivery. Expert Opinion on Drug Delivery. 3(1). 53–70. 82 indexed citations
19.
Olafsen, Tove, Vania Kenanova, Gobalakrishnan Sundaresan, et al.. (2005). Optimizing Radiolabeled Engineered Anti-p185HER2 Antibody Fragments for In vivo Imaging. Cancer Research. 65(13). 5907–5916. 123 indexed citations
20.
Kenanova, Vania, Tove Olafsen, Desiree Crow, et al.. (2005). Tailoring the Pharmacokinetics and Positron Emission Tomography Imaging Properties of Anti–Carcinoembryonic Antigen Single-Chain Fv-Fc Antibody Fragments. Cancer Research. 65(2). 622–631. 159 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R Boden Breakdown of academic impact, for papers by Erica Pyles Breakdown of academic impact, for papers by Kedan Lin Breakdown of academic impact, for papers by Kelly M. Flagella Breakdown of academic impact, for papers by Gregory Z. Ferl Breakdown of academic impact, for papers by Stephen I. Rudnick Breakdown of academic impact, for papers by William van Osdol Breakdown of academic impact, for papers by Christophe Lahorte Breakdown of academic impact, for papers by Thorsten Poethko Breakdown of academic impact, for papers by E Barendswaard
Rankless by CCL
2026